Welcome to our dedicated page for Im Cannabis SEC filings (Ticker: IMCC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking IM Cannabis Corp’s cross-border disclosures can feel like deciphering two rulebooks at once—U.S. SEC regulations and the strict cannabis frameworks of Israel and Germany. Licenses, EU-GMP supply agreements, and biological asset valuations are scattered across hundreds of pages.
Stock Titan’s AI reads every new filing the moment it lands on EDGAR, then translates the legal jargon into clear takeaways. Whether you open the latest IM Cannabis quarterly earnings report 10-Q filing or an 8-K about a German distribution contract, you’ll see plain-language highlights, red-flag alerts, and side-by-side metrics. Need “IM Cannabis insider trading Form 4 transactions”? Our platform streams Form 4 insider transactions in real-time, flags unusual executive stock movements, and links them to the dates of material events. Annual deep dives are just as accessible—“IM Cannabis annual report 10-K simplified” appears alongside concise AI summaries of cultivation yields, segment revenue, and pending regulatory risks.
Investors use these insights to:
- Spot patterns in “IM Cannabis executive stock transactions Form 4” before new product launches.
- Compare Israeli pharmacy sales across quarters with our “IM Cannabis earnings report filing analysis.”
- Quickly review “IM Cannabis proxy statement executive compensation” to evaluate incentive alignment.
From “IM Cannabis SEC filings explained simply” to “IM Cannabis 8-K material events explained,” Stock Titan consolidates every document type—10-Q, 10-K, S-1, 6-K, and more—into one continuously updated dashboard. Understanding IM Cannabis SEC documents with AI now takes minutes, not hours.
IM Cannabis Corp. appointed Asi Levi as its chief financial officer, effective immediately. He replaces former CFO Uri Birenberg, who resigned from the role for personal reasons.
Levi brings over 15 years of experience in finance and controlling positions, including prior CFO roles at Water Ways Technologies Inc. and DekelOil CI, and controller roles at SciSparc Ltd. and A2Z Cust2Mate Solutions Corp., with expertise in fundraising, financial planning, budgeting, and cash flow management under IFRS and other standards. The company expects to enter into its standard indemnification agreement with Levi on terms consistent with those for its other directors and executive officers, and this leadership change is incorporated by reference into IM Cannabis’s existing registration statements on Form F-3.
IM Cannabis Corp. (IMCC) filed a Form 6-K as a foreign private issuer to notify investors that it has issued a Cancellation Notice for a previously planned special meeting of security holders that was supposed to be held on December 29, 2025. The notice is dated November 14, 2025 and is attached as Exhibit 99.1. This report is also incorporated by reference into the company’s existing Form F-3 registration statements, meaning it becomes part of those registration documents for disclosure purposes.
IM Cannabis Corp. announced a CFO transition. Chief Financial Officer Uri Birenberg will step down for personal reasons and is expected to continue in the role until January 5, 2026, or an earlier date determined by the company. The company stated his decision was not due to any disagreement regarding operations, policies, or practices.
This 6-K (excluding designated press release paragraphs) is incorporated by reference into IM Cannabis’ Form F-3 registration statements, File Nos. 333-289571 and 333-288346.
IM Cannabis Corp. (IMCC) furnished a Form 6-K announcing a Notice of a Special Meeting of Security Holders to be held on December 29, 2025.
The notice is attached as Exhibit 99.1. This submission is incorporated by reference into the company’s Form F-3 registration statements (File Nos. 333-289571 and 333-288346).
IM Cannabis Corp. filed a Form 6-K reporting that it issued a press release dated October 23, 2025. The release states the company signed a non-binding term sheet to acquire a 60% stake in Innovative Quantum Computing Bio Data.
This filing signals a potential transaction at the term-sheet stage; terms and closing details are not included in the provided excerpt.
IM Cannabis Corp. furnished a Current Report on Form 6-K that includes a press release dated
IM Cannabis Corp. amended certain common share purchase warrants issued in its 2024 private placement by reducing the exercise price from C$4.32 to C$3.43 and extending the expiration date from November 12, 2026 to July 31, 2030. The warrants were originally exercisable upon issuance and, except for the exercise price and expiration, all other terms remain unchanged.
The amendments increase the timeframe and the lower threshold at which warrant holders may convert into common shares, which could raise the likelihood of exercise and therefore the potential for dilution if exercised. The Form of Warrant, the Form of Amendment and a press release are included as exhibits and the report is incorporated by reference into the company’s Form F-3 registration statements.
FAQ
What is the current stock price of Im Cannabis (IMCC)?
What is the market cap of Im Cannabis (IMCC)?
